Cargando…

Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial

BACKGROUND: The principal aim of this study was to investigate whether a caregiver-inclusive assistive technology intervention improved older care recipients’ functional autonomy and decreased the perceived burden of their family caregivers compared to customary care. METHODS: The study was a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Mortenson, W., Demers, Louise, Fuhrer, Marcus J., Jutai, Jeffrey W., Bilkey, Jessica, Plante, Michelle, DeRuyter, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907288/
https://www.ncbi.nlm.nih.gov/pubmed/29669536
http://dx.doi.org/10.1186/s12877-018-0783-6
_version_ 1783315500328026112
author Ben Mortenson, W.
Demers, Louise
Fuhrer, Marcus J.
Jutai, Jeffrey W.
Bilkey, Jessica
Plante, Michelle
DeRuyter, Frank
author_facet Ben Mortenson, W.
Demers, Louise
Fuhrer, Marcus J.
Jutai, Jeffrey W.
Bilkey, Jessica
Plante, Michelle
DeRuyter, Frank
author_sort Ben Mortenson, W.
collection PubMed
description BACKGROUND: The principal aim of this study was to investigate whether a caregiver-inclusive assistive technology intervention improved older care recipients’ functional autonomy and decreased the perceived burden of their family caregivers compared to customary care. METHODS: The study was a single-blind, mixed-methods, randomized controlled trial with baseline data collection and follow-ups at 6-, 22-, and 58-weeks after baseline evaluation, which was prospectively registered (ClinicalTrials.gov Identifier: NCT01640470. Registered 11/21/2011). Dyads comprising a care recipient and family caregiver were randomly assigned to either a caregiver-inclusive experimental group (N = 44) or a customary-care comparison group (N = 46). Eligible care recipients were aged ≥55 years and had one or more limitations with mobility or daily activities, and family caregivers provided at least four hours per week of assistance. Outcome measures were administered to both groups at baseline and at the three follow-up time points. The data collectors were blinded regarding participants’ intervention group. The primary outcome measures were the Functional Autonomy Measurement System to assess care recipients’ functional performance, and the Caregiver Assistive Technology Outcome Measure to assess caregivers’ burden. Qualitative interviews examined participants’ perceptions of the caregiver-inclusive and customary care interventions. RESULTS: The experimental intervention addressed significantly more dyad-identified problematic activities, but caregiver involvement was evident in both groups and outcomes were not significantly different over time. In both groups, care recipients’ functional autonomy declined significantly (P < .01), and caregivers’ activity-specific and overall burden decreased significantly (P < .01). CONCLUSIONS: Given the unintended congruence between the caregiver-inclusive and customary care interventions, the overall findings lend support for the provision of assistive technology to reduce caregiver burden.
format Online
Article
Text
id pubmed-5907288
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59072882018-04-30 Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial Ben Mortenson, W. Demers, Louise Fuhrer, Marcus J. Jutai, Jeffrey W. Bilkey, Jessica Plante, Michelle DeRuyter, Frank BMC Geriatr Research Article BACKGROUND: The principal aim of this study was to investigate whether a caregiver-inclusive assistive technology intervention improved older care recipients’ functional autonomy and decreased the perceived burden of their family caregivers compared to customary care. METHODS: The study was a single-blind, mixed-methods, randomized controlled trial with baseline data collection and follow-ups at 6-, 22-, and 58-weeks after baseline evaluation, which was prospectively registered (ClinicalTrials.gov Identifier: NCT01640470. Registered 11/21/2011). Dyads comprising a care recipient and family caregiver were randomly assigned to either a caregiver-inclusive experimental group (N = 44) or a customary-care comparison group (N = 46). Eligible care recipients were aged ≥55 years and had one or more limitations with mobility or daily activities, and family caregivers provided at least four hours per week of assistance. Outcome measures were administered to both groups at baseline and at the three follow-up time points. The data collectors were blinded regarding participants’ intervention group. The primary outcome measures were the Functional Autonomy Measurement System to assess care recipients’ functional performance, and the Caregiver Assistive Technology Outcome Measure to assess caregivers’ burden. Qualitative interviews examined participants’ perceptions of the caregiver-inclusive and customary care interventions. RESULTS: The experimental intervention addressed significantly more dyad-identified problematic activities, but caregiver involvement was evident in both groups and outcomes were not significantly different over time. In both groups, care recipients’ functional autonomy declined significantly (P < .01), and caregivers’ activity-specific and overall burden decreased significantly (P < .01). CONCLUSIONS: Given the unintended congruence between the caregiver-inclusive and customary care interventions, the overall findings lend support for the provision of assistive technology to reduce caregiver burden. BioMed Central 2018-04-18 /pmc/articles/PMC5907288/ /pubmed/29669536 http://dx.doi.org/10.1186/s12877-018-0783-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ben Mortenson, W.
Demers, Louise
Fuhrer, Marcus J.
Jutai, Jeffrey W.
Bilkey, Jessica
Plante, Michelle
DeRuyter, Frank
Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title_full Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title_fullStr Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title_full_unstemmed Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title_short Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
title_sort effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907288/
https://www.ncbi.nlm.nih.gov/pubmed/29669536
http://dx.doi.org/10.1186/s12877-018-0783-6
work_keys_str_mv AT benmortensonw effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT demerslouise effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT fuhrermarcusj effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT jutaijeffreyw effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT bilkeyjessica effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT plantemichelle effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial
AT deruyterfrank effectsofacaregiverinclusiveassistivetechnologyinterventionarandomizedcontrolledtrial